About PDA Workspace
PDA Workspace provides all of the tools needed to collaborate as groups with your PDA colleagues to successfully carry out your roles and responsibilities.
TR 42 Revision 2016
TR 60-3: Ongoing Process VerificationBased on outstanding questions and observations from PDA members and industry in general, there is significant interest in the development of a Continued Process Validation/Ongoing Process Validation (CPV/OPV) PDA Technical Report. During recent Process Validation Interest Group discussions over the past several years, the following items were discussed and commented: There is a need to: • Expand and clarify the CPV/OPV requirement defined in TR60. • Clarification of terms, e.g. Continuous, Continued Process/Quality Verifications (CQV). • Suggest statistical tools and where and when to use (or not use) • Guide and understand how to apply CPV/OPV for both new and legacy products • Provide examples representing multiple dosage forms • Define the CPV/OPV versus Annual Product Reviews (APR) and Product Quality Review (PQR) relationship (They are not the same.) • Define what signals that should be tracked and trended within CPV such as critical quality attributes (CQAs), critical process parameters (CPPs), in-process controls (IPCs), critical material attributes (CMAs), etc. • Define how often CPV should be reported out • Define how signals and trends should be reacted to within CPV/OPV • Define how to apply quality risk management principles (QRM) to CPV/OPV • Define the relationship between stage 2b and stage 3. ▪ When and how to reduced enhanced sampling • Define short term and long term CPV (How to select long term control limits